Assistant Professor, Medicine, Brown University Program in Medicine
Hematology
Dr. Eric P. Winer, MD
|
|
Give Review
Eric P. Winer, MD works in the field of Hematology. He went to medical school at University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is a top medical college. University of North Carolina at Chapel Hill School of Medicine is ranked 22/2 in Research/PrimaryCare. Doctor Eric P. Winer, MD is also published. He has 21 publications published. The lastest publication: "Genomics in acute myeloid leukemia: from identification to personalization.'
Publications
- Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic Lymphoma.
- Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid Tumors: a randomized phase I study.
- Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell Lymphoma.
- Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia.
- Primary refractory Hodgkin Lymphoma: limited options and poor survival -- but not always.
- Sites of extranodal involvement are prognostic in patients with diffuse large B-cell Lymphoma in the rituximab era: An analysis of the surveillance, epidemiology and e...
- Population-based prognostic factors for survival in patients with Burkitt Lymphoma: An analysis from the Surveillance, Epidemiology, and End Results database.
- Unusual blasts with basophilic granules in 2 cases of de novo acute myeloid leukemia with inv3(q21q26.2) and monosomy 7 and coexpression of CD2 and CD31.
- Prognosis in primary effusion Lymphoma is associated with the number of body cavities involved.
- CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid Malignancies.
- HIV-Negative Plasmablastic Lymphoma: Not in the Mouth.
- CD30-positive EBV-associated diffuse large B-cell Lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemia.
- Epstein-barr virus-positive diffuse large B-cell Lymphoma of the elderly: what we know so far.
- Chronic lymphocytic leukemia: something old, something new and something borrowed...
- Alphabet soup: RAEB, HMA, DOE, and AFOP.
- Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic Lymphoma.
- Nonengraftment haploidentical cellular immunotherapy for refractory Malignancies: tumor responses without chimerism.
- Cryopreservation of hematopoietic stem cells.
- GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDS.
- Genomics in acute myeloid leukemia: from identification to personalization.
Schools
Yale University School Of Medicine
Yale New Haven Hospital
Duke University
DanaFarber Cancer Institute Chair Executive Committee for Clinical Programs
Conditions Treated
- Anemia
- Bladder Cancer
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
Tufts Medical Center -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1609852516 | |
| NPPES Provider LastName | WINER | |
| NPPES Provider FirstName | ERIC | |
| NPPES Provider ZIPCode | 029034923 | |
| NPPES Provider State | RI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 423.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 2.84 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609852516 |
| Last Name Of The Provider | WINER |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
|
Dr. Ahmad S. Al-Homsi, MD |
|
|
Dr. Bharti C. Rathore, MD
 This Doctor is OpenDoctor Recommended.
|